LAIDX
Price
$11.78
Change
+$0.05 (+0.43%)
Updated
Jun 2 closing price
Net Assets
531.9M
TRTIX
Price
$26.28
Change
+$0.15 (+0.57%)
Updated
Jun 2 closing price
Net Assets
17.12B
Interact to see
Advertisement

LAIDX vs TRTIX

Header iconLAIDX vs TRTIX Comparison
Open Charts LAIDX vs TRTIXBanner chart's image
LAIDX vs TRTIX Comparison Chart in %
View a ticker or compare two or three
VS
LAIDX vs. TRTIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LAIDX is a Buy and TRTIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRTIX has more cash in the bank: 17.1B vs. LAIDX (532M). LAIDX pays higher dividends than TRTIX: LAIDX (2.71) vs TRTIX (2.52). LAIDX was incepted earlier than TRTIX: LAIDX (18 years) vs TRTIX (11 years). LAIDX (0.73) is less costly to investors than TRTIX (0.68). LAIDX is a more actively managed with annual turnover of: 66.00 vs. TRTIX (15.00). TRTIX has a lower initial minimum investment than LAIDX: TRTIX (500000) vs LAIDX (1000000). TRTIX annual gain was more profitable for investors over the last year : 29.56 vs. LAIDX (26.88). TRTIX return over 5 years is better than : 84.98 vs. LAIDX (57.06).
LAIDXTRTIXLAIDX / TRTIX
Total Expense Ratio0.730.68107%
Annual Report Gross Expense Ratio0.730.68107%
Fund Existence18 years11 years-
Gain YTD10.88811.05099%
Front LoadN/AN/A-
Min. Initial Investment1000000500000200%
Min. Initial Investment IRAN/AN/A-
Net Assets532M17.1B3%
Annual Yield % from dividends2.712.52108%
Returns for 1 year26.8829.5691%
Returns for 3 years78.3189.1388%
Returns for 5 years57.0684.9867%
Returns for 10 years117.02151.1377%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYNA146.0911.16
+8.27%
Synaptics
ROST223.78-0.29
-0.13%
Ross Stores
LCNB16.56-0.09
-0.54%
LCNB Corp
TDAY7.79-0.37
-4.53%
USA TODAY Co. Inc.
HOWL0.43-0.04
-7.64%
Werewolf Therapeutics